CELEBRATING THE 70TH ANNIVERSARY OF A BLOCKBUSTER THAT CREATED LEGENDS AND INFLUENCED THE NOIR GENRE
BOLLYWOOD blockbuster Baazi became a big game-changer when it released on July 1, 1951, and that is why its 70th anniversary should be rightly celebrated this week.
The iconic classic popularised the Hindi noir genre, launched incredible new talent, had unforgettable moments, and introduced a new director who would go on to become one of the greatest filmmakers in history. That perfect moment in time was the result of a promise which had been made years earlier.
When struggling actor Dev Anand befriended aspiring filmmaker Guru Dutt, he promised to hire him if he ever became a star. Dutt vowed to cast his close friend if he became a filmmaker first. While Dutt struggled, Anand became a famous actor and soon launched his own production house Navketan Films. For the banner’s second home production Baazi, he kept his promise and hired Guru Dutt to make his directorial debut. That wasn’t the only truly inspired decision he would take for his ambitious production.
Future legend Balraj Sahni was struggling to make his mark as an actor and Anand hired him to write the screenplay, which proved be pathbreaking in the themes it covered. Meanwhile, another future film icon SD Burman was feeling disillusioned in Bollywood as he was not able to get any meaningful work and was persuaded not to quit by Anand. He roped him in to deliver the magnificent music for Baazi and that would start a dream run of stunning soundtracks for the legendary composer.
Around the same time a young poet named Sahir Ludhianvi was struggling to make a breakthrough and despite his lack of a track record was hired to write the lyrics. Those Baazi lyrics would be the first major step towards Ludhianvi becoming one of the greatest and most influential lyricists in cinema history.
Meanwhile, an unknown dancer named Zohra Sehgal had made a name for herself in theatre and was brought on board to choreograph the songs. She would also go on to become a dance legend and an internationally renowned actress, who worked well into her nineties.
Dev Anand would, of course, play the lead role and despite having the choice of major leading ladies, the team took the inspired decision of casting talented young actress Geeta Bali, who had done a few films but nothing noteworthy. She would set the screen on fire with her presence and become a huge star after the movie released. Her playful performance of songs like Tadbeer Se Bigdi Hui Taqdeer Bana Le would introduce the kind of sensuality that hadn’t been seen before by a leading lady and would put a dent in the conservative culture that had enveloped Bollywood, since strict censor laws had been introduced two decades earlier. This would also include one particularly suggestive outfit not seen before on-screen in India.
The second leading lady would be a beauty pageant winner named Mona Singha, who had been noticed by lead star Dev Anand’s elder brother Chetan Anand. She was rechristened as Kalpana Kartik and made a winning debut. She would go on to have a great Bollywood career and marry Baazi lead star Dev Anand a few years later. Anand wasn’t the only one who met his future wife on Baazi because an aspiring singer named Geeta Roy was given a large bulk of the songs, instead of a more established name, and they would turn her into a superstar and win the heart of director Guru Dutt, who would marry her two years later.
The other inspired piece of casting had perhaps the most incredible subplot associated with the brilliant Baazi story. Balraj Sahni, who had written Baazi, was on a bus and saw the conductor Badruddin Jamaluddin Kazi entertaining passengers with his jokes. He got him to audition for director Dutt, who was equally impressed and cast him as the comic relief in the movie. Dutt rechristened the loveable bus conductor after famous liquor brand Johnny Walker and he would go on to become one of the greatest on-screen comedians in Bollywood history. Such was his impact that he would influence pretty much every comedian in Bollywood that followed, including modern-day ones 70 years later.
The film itself, inspired by 1946 Hollywood film Gilda, would attempt a new kind of noir genre that had not been properly attempted in Hindi cinema before with a morally ambiguous hero and an unpredictable vamp. Debutante director Dutt would introduce the kind of filmmaking techniques seen in Hollywood with his camera angles, lighting and sharp camerawork. The director would also integrate songs into the storyline rather than randomly placing them into a plot like others had done.
Most importantly, the performances would be understated and rooted in reality. Apart from being a homage to 1940s Hollywood noir films, Baazi also made important social commentary on subjects like capitalism.
Baazi became a huge blockbuster when it released and the second highest grossing Bollywood film of 1951, beaten only by the record-breaking Awaara. The film would elevate Dev Anand to superstar status, putting him on par with Dilip Kumar and Raj Kapoor, to create the golden era’s holy trinity of leading men. The film would turn the many relative newcomers into major stars and influence urban crime films that came out of Bollywood in subsequent decades. It would also help shape a new type of Bollywood hero, who was tough on the outside but had a heart of gold.
Everything came together to create a classic that launched stars and changed Bollywood. That is why it remains an important moment in movie time even 70 years later.
Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
A new discount deal with UK suppliers will limit the increase for patients.
Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
NHS pricing remains unaffected due to separate arrangements.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.
Why the price rise was announced
Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.
Discount deal for UK suppliers
The revised agreement will see the top-dose price set at £247.50 for suppliers. While pharmacies and private providers will still add their own margins, the increase for patients is now likely to remain under 50% for higher doses, and even lower for smaller doses.
Eli Lilly confirmed:
“We are working with private providers on commercial arrangements to maintain affordability and expect these to be passed onto patients when the change is effective on 1 September.”
Impact on consumers
Around 1.5 million people in the UK are currently on weight-loss drugs, with more than half using Mounjaro. Most of these patients—around 90%—pay privately through online services or high street pharmacies.
Prices vary between providers, depending on the level of lifestyle and dietary support offered alongside the injections.
Olivier Picard of the National Pharmacy Association said:
“This rebate will mitigate some of the impact of the increase, but patients should still anticipate seeing a rise in prices from 1 September.”
NHS pricing unchanged
The deal does not affect the NHS, which has secured its own heavily-discounted price for patients prescribed the weekly injection.
Mounjaro works by helping patients feel fuller for longer, reducing food intake and supporting weight loss of up to 20% of body weight.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)
CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.
GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. Research estimates chickenpox in childhood leads to £24 million in lost income and productivity annually.
Minister of State for Care, Stephen Kinnock, said: “We’re giving parents the power to protect their children from chickenpox and its serious complications, while keeping them in nursery or the classroom where they belong and preventing parents from scrambling for childcare or having to miss work. This vaccine puts children’s health first and gives working families the support they deserve. As part of our Plan for Change, we want to give every child the best possible start in life, and this rollout will help to do exactly that.”
Dr Gayatri Amirthalingam, Deputy Director of Immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal. It is excellent news that from next January we will be introducing a vaccine to protect against chickenpox into the NHS routine childhood vaccination programme – helping prevent what is for most a nasty illness and for those who develop severe symptoms, it could be a life saver.”
Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “This is a hugely positive moment for families as the NHS gets ready to roll out a vaccine to protect children against chickenpox for the first time, adding to the arsenal of other routine jabs that safeguard against serious illness.”
The eligibility criteria will be set out in clinical guidance, and parents will be contacted by their GP surgery if their child is eligible.
WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.
Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.
“For so long, so many women haven’t been listened to by the world of medicine,” Munchetty said. “I knew this from my own experience of not being given adequate pain relief, or waiting years for a diagnosis. My motivation was to help women and people who love women to advocate better for women’s health.”
The book blends Munchetty’s personal journey with the voices of other women who have faced similar struggles, alongside expert insights from medical professionals. Its purpose, she said, is clear: to empower people to fight for their health.
“We need to be unafraid of saying how we have been weakened by our symptoms,” the BBC presenter said.
“Too often, we try to keep afloat, keep our head above water, but we don’t want to seem weak. That needs to change.”
Munchetty’s candour is striking. She describes the shame of being told her excruciating periods were “just normal,” leaving her to feel weak and whiny for struggling.
“You might as well have told me people have heart attacks while I’m having a heart attack,” she said. “Debilitating pain is serious — it may not be lifelimiting, but it is life-impacting.”
Her determination to challenge that culture led to her giving evidence in parliament, contributing to what became a Women and Equalities Committee report, published in December 2024.
The report made headlines for its stark conclusion: medical misogyny exists.
For Munchetty, seeing that phrase in black and white was transformative. “It was almost self-affirming,” she said. “We now know it’s there, so we can challenge it. Women can say: I know my body, I know there’s not enough research, and I am entitled to push for answers.”
The parliamentary report went further than acknowledgement. It called for ring-fenced funding for women’s health hubs, better training for GPs, and greater investment in research into reproductive conditions like adenomyosis and endometriosis.
It highlighted how symptoms are routinely dismissed as “normal,” delaying diagnosis and disrupting women’s careers, education and daily lives. Munchetty wrote in her book — referencing the report — that medical misogyny is not about blaming individual doctors, but about challenging a system built on insufficient research into women’s bodies.
“It gives women the language and the confidence to not just be heard, but to insist on being taken seriously,” she wrote.
Her book also tackles the additional barriers faced by women from minority communities, who may be discouraged by stigma or embarrassment from speaking about menstruation or menopause. To them, Munchetty has a clear message: “You are so much more valuable than you realise. If you don’t prioritise your health, you are lessening your ability to hold up everyone around you.”
Those featured in the book are friends, colleagues, charities and everyday women who contributed their stories, many for the first time. “I was surprised at how many friends are in that book with such powerful experiences,” Munchetty said.
“It told me all the more that we’re not speaking about it, and that it is sadly so very common.”
At a launch event for the book, contributors, family and experts filled the room with what Munchetty describes as an “electric and inspiring atmosphere.”
She said, “It was full of joy, of women who felt safe to speak up and be heard. This is not a whiny book — it’s a positive book. People felt they were part of making things better, part of this women’s health revolution.”
For Munchetty, writing the book was exhausting, but transformative, she said.
“I never thought I’d be an author. I’m a journalist. But this is journalism — facilitating people’s stories to be told powerfully and truthfully. People trusted me, and I’m proud of that.”
And Munchetty’s aim is for the book to be a tool for change: arming women with the language, confidence and strategies to advocate for their health.
“It’s not easy to admit you need help, and it’s not instinctive for women to prioritise themselves,” she said. “But this book will help you do that. It’s the silent friend who has your back and gives you strength.”
It’s Probably Nothing - Critical Conversations on the Women’s Health Crisis is now available in all good bookshops
The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.
The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”
Several dignitaries were honoured at the ceremony, including Cllr Anjana Patel, Mayor of Harrow; Anuradha Pandey, Hindi and Cultural Attaché at the High Commission of India; Kamakshi Jani of the Royal Navy; Councillors Janet Mote, Nitin Parikh and Mina Parmar; Krishnaben Pujara, Chairperson of ALL UK; and Truptiben Patel, President of the Hindu Forum of Britain.
Organisers said the launch marks the beginning of a new spiritual and cultural hub for London’s Hindu community, offering a centre for devotion, learning and community service.
Martin Dickie has announced his departure from BrewDog and the alcohol industry.
He co-founded the Ellon-based brewer with James Watt in 2007.
Dickie cited family time and personal reasons for his exit.
His departure follows recent bar closures as part of a company restructuring.
BrewDog confirmed no further leadership changes will follow.
BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.
Early beginnings
Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.
Leadership changes
James Watt stepped down as chief executive last year after 17 years in the role, moving into a non-executive position as “captain and co-founder.” Dickie’s exit marks another major shift in the company’s founding leadership.
Dickie’s statement
“Leaving BrewDog isn’t easy, but I’m ready to spend less time travelling and spend some more time at home with my young family,” Dickie said. He added: “It has been an honour to have worked with incredible, like-minded colleagues who live in a world of flavour and experimentation. In James Taylor and Lauren Carrol, BrewDog is in very strong hands and I will always remain a massive fan.”
Company response
BrewDog chief executive James Taylor praised Dickie’s contribution, highlighting his focus on product quality, workplace safety, sustainable supplier relationships, and new product development. “Martin’s contributions to BrewDog have been immeasurable,” Taylor said. “His creativity, passion, and relentless drive have shaped our company over the years and inspired countless others in the industry.”
Recent challenges
The announcement comes a month after BrewDog closed ten of its bars, including its flagship Aberdeen Gallowgate site and a Dundee outlet, citing commercial unviability. The company stressed that Dickie’s departure will not result in further leadership changes.